Fibroblasts from amyotrophic lateral sclerosis patients harbouring mutated TDP-43 have disrupted Nrf2 signalling, where basal Nrf2 activity is elevated but their response to the Nrf2 inducer arsenite [114] is impaired [163]. The gene discussed is TARDBP; the disease is amyotrophic lateral sclerosis.